Target intelligence / Profile preview

Endosomal membrane phospholipid bilayer

Molecular classification
Other, Cellular membrane
01

Overview

The endosomal membrane phospholipid bilayer is a dynamic lipid structure that defines the boundary of endocytic vesicles, playing a central role in the sorting, trafficking, and degradation of internalized proteins and lipids (Gruenberg, J., 2020, Nature Reviews Molecular Cell Biology). It is characterized by a unique lipid composition, including phosphoinositides and bis(monoacylglycero)phosphate, which regulate the recruitment of various cytosolic proteins involved in membrane remodeling and fusion. In the context of infectious diseases, many viruses exploit the endosomal membrane as a site for cell entry, relying on the acidic luminal environment to trigger conformational changes in viral proteins that lead to membrane fusion (Hu, T. Y., et al., 2020, International Journal of Antimicrobial Agents). Pharmacological intervention often involves the use of lysosomotropic weak bases that accumulate in the endosome, raising the pH and thereby inhibiting viral entry or altering protein processing. Additionally, the endosomal membrane represents a major barrier for the delivery of macromolecular drugs, such as mRNA and siRNA, leading to the development of delivery systems designed to destabilize the bilayer and promote endosomal escape (Smith, S. A., et al., 2019, Bioconjugate Chemistry).

Other names
Endosomal membraneEndosomal lipid bilayerEndocytic membrane
02

Mechanism of action

Drugs targeting the endosomal membrane typically act by increasing endosomal pH to inhibit pH-dependent viral fusion, or by physically disrupting the bilayer to facilitate the escape of therapeutic molecules into the cytosol.

03

Biological functions

EndocytosisIntracellular traffickingProtein sortingViral entryNutrient uptakeSignal transduction
04

Disease associations

InfectionLysosomal storage diseaseNeurodegenerative diseaseCancer
05

Safety considerations

Lysosomal storage-like phenotypesPhospholipidosisNon-specific membrane disruptionSystemic toxicity due to lack of organelle specificity
06

Interacting drugs

Chloroquine

4 more in the full profile.

07

Biomarkers

Endosomal pHBis(monoacylglycero)phosphate (BMP) levelsLysobisphosphatidic acid (LBPA) levels

Beyond the preview

Go deeper on Endosomal membrane phospholipid bilayer.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endosomal membrane phospholipid bilayer.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call